Ivermectin futile for mild to moderate COVID-19, study finds

Feb 18, 2022

In the ivermectin group, 22% became severely ill, vs 17% in the standard-care group.

Mary Van Beusekom | News Writer | CIDRAP NewsFeb 18, 2022In the ivermectin group, 22% became severely ill, vs 17% in the standard-care group.Read More

Leave a Reply

Your email address will not be published.